Rapport Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $323k | 11k | 29.70 |
| 2025-06-30 | $124k | 11k | 11.37 |
| 2025-03-31 | $109k | 11k | 10.03 |
| 2024-12-31 | $101k | 5.7k | 17.74 |
| 2024-09-30 | $117k | 5.7k | 20.48 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors